DOJ Seizes Medical Records: Hospitals Quietly Halt Youth Gender Care

The fight over transgender healthcare for minors isn't just happening in state capitals anymore. It's happening in hospital compliance offices. In the first few months of 2026, major programs at NYU Langone and San Diego’s Rady Children’s Hospital shut down their medical services for minors. These closures happened despite the fact that the care is still perfectly legal in New York and California. This 'silent withdrawal' shows that hospitals are more worried about their federal funding than they are about state shield laws. The real pressure started in July 2025, when the Department of Justice issued subpoenas for years of patient records and internal emails. For these hospitals, the threat of a federal investigation is much scarier than the loss of revenue from these clinics.

The money involved is significant. According to Grand View Research, the global market for gender-affirming care was worth $2.1 billion in 2022 and has been growing at double-digit rates. Companies like AbbVie and Endo International see a steady stream of income from drugs like Lupron and Supprelin LA. But the financial math is changing. In some regions, medical malpractice insurance for these clinics has reportedly spiked by more than 40%. For hospital administrators, what once looked like a growth sector is starting to look like a toxic asset.

To be clear, Gender-Affirming Care is a clinical framework that includes social, psychological, and medical interventions. This can mean hormone therapy or puberty blockers meant to align a person's physical traits with their identity. On the other side are Shield Laws. These are state rules that try to stop local doctors from being targeted by out-of-state investigators. But here's the kicker: those laws don't offer much protection when the federal government is the one asking for the files.

“The global gender-affirming care market was valued at $2.1 billion in 2022 and is projected to grow by 11.5% annually, but hospitals are now weighing that revenue against federal record seizures.”

The medical consensus in the U.S. is increasingly at odds with the rest of the world. While the American Academy of Pediatrics calls the science 'settled,' hospitals here can't ignore what's happening overseas. In April 2024, the UK’s NHS released the Cass Review, which led to a nearly total ban on puberty blockers because the evidence was 'remarkably weak.' Similar shifts in Sweden, Finland, and Norway have moved the focus toward therapy instead of medicine. U.S. health systems still back the care publicly, but internal documents suggest administrators are using these European policy shifts to justify closing their own pediatric programs.

The regulatory pressure hit a boiling point on May 13, 2026. New reports suggest the DOJ is using HIPAA loopholes to get minor patient records, effectively bypassing state shield laws. Those laws were meant to stop state-level prosecutors in places like Texas or Idaho, but they’re useless against federal demands. Data from OpenSecrets shows that medical associations spent millions on lobbying in 2025, but they didn't put that money toward fighting these federal record seizures. That has left individual clinics to face the DOJ on their own.

What we don't know yet is how many 'soft closures' are happening. This is when a clinic stays open on paper but stops taking new minor patients for hormone therapy. It creates a waitlist that never moves. There's also no verified count of how many patients have been 'force-tapered' off their medications. Families at NYU Langone and Baystate Health say thousands of kids are being cut off from care with less than 60 days' notice. That actually goes against the Endocrine Society’s own rules for keeping patients safe.

For families and taxpayers, this is part of a bigger trend in American healthcare. Services vanish the moment the legal and political risks threaten the bottom line. Look at Children’s Hospital Colorado: they only started providing care again after a Supreme Court order on May 19, 2026. Right now, medical access is being decided by judges rather than doctors. The next phase will likely hit the insurance sector. Watch for providers like UnitedHealthcare and Blue Cross Blue Shield to drop coverage for pediatric gender services. They'll cite the 'evolving legal landscape,' but it's really about cost-cutting.